CME Group Inc. (NASDAQ:CME – Get Rating) – Research analysts at Jefferies Financial Group decreased their FY2023 earnings per share (EPS) estimates for CME Group in a note issued to investors on Tuesday, January 10th. Jefferies Financial Group analyst D. Fannon now expects that the financial services provider will earn $8.30 per share for the year, down from their prior estimate of $8.40. The consensus estimate for CME Group’s current full-year earnings is $7.99 per share. Jefferies Financial Group also issued estimates for CME Group’s Q4 2023 earnings at $1.99 EPS.
CME Group (NASDAQ:CME – Get Rating) last released its quarterly earnings data on Wednesday, October 26th. The financial services provider reported $1.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.05. CME Group had a return on equity of 10.06% and a net margin of 54.01%. The firm had revenue of $1.23 billion during the quarter, compared to analyst estimates of $1.23 billion.
CME Group Stock Performance
CME Group stock opened at $176.71 on Thursday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a fifty day moving average price of $173.83 and a two-hundred day moving average price of $185.62. CME Group has a 52-week low of $166.54 and a 52-week high of $256.94. The firm has a market capitalization of $63.57 billion, a P/E ratio of 24.04, a P/E/G ratio of 2.69 and a beta of 0.40.
CME Group Increases Dividend
The business also recently announced a None dividend, which will be paid on Wednesday, January 18th. Shareholders of record on Wednesday, December 28th will be issued a dividend of $4.50 per share. The ex-dividend date is Tuesday, December 27th. This is a boost from CME Group’s previous None dividend of $3.25. CME Group’s dividend payout ratio (DPR) is 54.42%.
Insiders Place Their Bets
In other CME Group news, Director William R. Shepard purchased 48,645 shares of the company’s stock in a transaction dated Friday, November 4th. The shares were bought at an average price of $170.00 per share, with a total value of $8,269,650.00. Following the completion of the transaction, the director now directly owns 247,843 shares in the company, valued at approximately $42,133,310. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.30% of the company’s stock.
Institutional Investors Weigh In On CME Group
A number of hedge funds have recently modified their holdings of the business. First Hawaiian Bank raised its position in CME Group by 9.0% in the 4th quarter. First Hawaiian Bank now owns 3,916 shares of the financial services provider’s stock valued at $658,000 after buying an additional 324 shares during the last quarter. State of Alaska Department of Revenue raised its position in CME Group by 1.0% in the 4th quarter. State of Alaska Department of Revenue now owns 50,352 shares of the financial services provider’s stock valued at $8,467,000 after buying an additional 475 shares during the last quarter. DNB Asset Management AS raised its position in CME Group by 1.5% in the 4th quarter. DNB Asset Management AS now owns 68,731 shares of the financial services provider’s stock valued at $11,558,000 after buying an additional 1,001 shares during the last quarter. Telemus Capital LLC acquired a new stake in CME Group in the 4th quarter valued at approximately $359,000. Finally, McElhenny Sheffield Capital Management LLC acquired a new stake in CME Group in the 4th quarter valued at approximately $788,000. Institutional investors and hedge funds own 85.09% of the company’s stock.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
- Get a free copy of the StockNews.com research report on CME Group (CME)
- Optimism About Global Demand For Metals Boosts BHP, Other Miners
- Exxon Mobil Expects Earnings and Cash Flow to Grow
- Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
- Is The Great Alibaba Recovery About To Begin?
- KB Home, Another Reason To Shed Home Building Stocks
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.